PetVivo Holdings, Inc. (PETV)
| Previous close | 2.6650 |
| Open | 2.6582 |
| Bid | 2.6200 x 1100 |
| Ask | 2.6600 x 1800 |
| Day's range | 2.6200 - 2.6599 |
| 52-week range | 1.2200 - 2.9500 |
| Volume | |
| Avg. volume | 16,642 |
| Market cap | 28.531M |
| Beta (5Y monthly) | 1.95 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2022
MINNEAPOLIS, MN, US, Feb. 02, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Thursday, February 9, 2023 after market close. The company will host a conference call to discuss these results at 4:00 p.m. CT (5:00 p.m. ET) on the same day. Attendees of the live webcast of the conference call and related earnings release ma
- GlobeNewswire
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE MINNESOTA VETERINARY MEDICAL ASSOCIATION ANNUAL MEETING IN MINNEAPOLIS, MINNESOTA
MINNEAPOLIS, Jan. 30, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it will be exhibiting at the 2023 Minnesota Veterinary Medical Association Annual Meeting from February 2nd to February 4th, 2023 at the Hyatt Regency in Minneapolis, Minnesota. "We are incredibly excited to showcase our innovative product
- GlobeNewswire
PETVIVO HOLDINGS, INC. TO PARTICIPATE IN THE LYTHAM PARTNERS INVESTOR SELECT CONFERENCE
PetVivo Holdings, Inc. John Lai, Chief Executive Officer PetVivo Holdings, Inc. MINNEAPOLIS, Jan. 26, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced that the Company will be participating in the Lytham Partners Investor Select Conference taking place virtually on January 31, 2023. John Lai, Chief Executive
